InSphero at PBSS 2025
Join us at PBSS 2025 in Foster City, California. This exciting symposium will bring together experts who will discuss the latest developments in New Approach Methodologies and technologies that seek to phase out animal testing in drug development and discovery.
Connect with us and the Pharmaceutical and Bioscience Society on Monday, October 20th, as we explore the new strategies changing the world of drug safety assessments and therapeutic innovation.
Quick navigation
Meet our Team at PBSS 2025


Bruno Filippi, PhD
Vice President, Liver Safety
Bruno Filippi, PhD
Vice President, Liver Safety
Bruno is an experienced and versatile biologist who worked at the crossroads between cell biology, advanced in vitro models, and biochemistry in various European academic and technical research institutions for more than 15 years. Bruno holds a PhD in cell biology from the University of Zürich and thrives to turn innovation into applications.




Sue Grepper, PhD
Director of Business Development
Sue Grepper, PhD
Director of Business Development
Sue is an experienced scientist with over 20 years of in vitro research experience. Sue holds a PhD in Pharmacology/Toxicology from the University of Arizona. She has dedicated the majority of her career to helping scientists achieve their research goals with human cell-based models.


Scientific Talk at PBSS 2025
Primary Liver Spheroids for Drug Safety Assessment: Overview, Case Studies, and the Roadmap to FDA Qualification
Date: Monday, October 20, 2025 | 1:05 - 1:40 PM
Location: Crown Plaza Hotel, Foster City, CA


Bruno Filippi, PhD
Vice President, Liver Safety
Bruno Filippi, PhD
Vice President, Liver Safety
Bruno is an experienced and versatile biologist who worked at the crossroads between cell biology, advanced in vitro models, and biochemistry in various European academic and technical research institutions for more than 15 years. Bruno holds a PhD in cell biology from the University of Zürich and thrives to turn innovation into applications.

